Lukket for ansøgninger

IMI_ECSEL Joint Activity – Trials@Home

The proposal(s) submitted to call 3 should deliver Next Generation Digital Technologies for RDCTs, that complement to or extent on the technology scan activity of the running IMI JU project “Trials@Home” that will identify barriers, enablers and data management for the RDCTs. The selected pre-competitive RIA project(s) resulting from ECSEL Call 3 should reinforce the European Medical Technology sector and promote the collaboration with the IMI stakeholders.

Hvem?

All types of organisations can participate in the call, but the Danish part of the consortium must include a commercial or a user organization other than a university

Hvad?

The topic of the call is “Next Generation Digital Technologies for Remote Decentralised Clinical Trials (RDCTs)”. RDCTs represent a novel approach to operational clinical trials, which will move the key research activities away from typical clinical trial sites (e.g. hospitals and clinics) and closer to the study participant, for example via the use of home health nursing or telemedicine solutions.

Hvor meget?

IFDs can co-fund up to €300.000 per Danish partner and a maximum of €500.000 to all Danish partners in an application. EU co-finance rate will be deducted from IFDs funding rates for International projects. The EU funding will be added to IFDs investment in the project. IFD has allocated €1 mio. to the call

The topic of the call is “Next Generation Digital Technologies for Remote Decentralised Clinical Trials (RDCTs)”. RDCTs represent a novel approach to operational clinical trials, which will move the key research activities away from typical clinical trial sites (e.g. hospitals and clinics) and closer to the study participant, for example via the use of home health nursing or telemedicine solutions. The proposal(s) submitted to call 3 should deliver Next Generation Digital Technologies for RDCTs, that complement to or extent on the technology scan activity of the running IMI JU project “Trials@Home” that will identify barriers, enablers and data management for the RDCTs. The selected pre-competitive RIA project(s) resulting from ECSEL Call 3 should reinforce the European Medical Technology sector and promote the collaboration with the IMI stakeholders.

 

EU call conditions:

Applicants are invited to pay special attention to the eligibility conditions:

  1. its content corresponds, wholly or in part, to the topic description for which it is submitted
  2. minimum mumber of legal entities: at least 3 legal entities; each of the three must be established in a different Member State or associated country; all three legal entities must be independent of each other.
  3. duration of the project (limited to 3 years),
  4. size of the consortia (maximum 50 participants) 
  5. budget capping per project (the maximum EU contribution that can be requested is 5 M€) and per partner (the maximum EU contribution a beneficiary can request in a project is limited to 40% of the total EU funding of the project).

Non-compliance with conditions 1-5 leads to exclusion (proposal declared not eligible and not evaluated)

Read more here

Innovation Fund Denmarks call conditions:

  1. The Danish part of the consortium must include a commercial or a user organization other than a university
  2. IFDs can co-fund up to €300.000 per Danish partner and a maximum of €500.000 to all Danish partners in an application.
  3. EU co-finance rate will be deducted from IFDs funding rates for International projects. The actual EU funding will, however, be added to IFDs investment in the project.
  4. IFD has allocated €1 mio. to the call